<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>23</Volume>
      <Issue>3</Issue>
      <PubDate PubStatus="epublish">
        <Year>2024</Year>
        <Month>05</Month>
        <Day>27</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Nebulized Dexmedetomidine Alleviates Oxidative Stress in Ventilator-induced Lung Injury via Keap1-Nrf2-ARE Pathway</title>
    <FirstPage>330</FirstPage>
    <LastPage>338</LastPage>
    <AuthorList>
      <Author>
        <FirstName>Jun</FirstName>
        <LastName>Zha</LastName>
        <affiliation locale="en_US">Department of Anesthesiology, The Second Affiliated Hospital, Soochow University, Suzhou, China AND Department of Anesthesiology, The Second Affiliated Hospital, Wannan Medical College, Wuhu, China</affiliation>
      </Author>
      <Author>
        <FirstName>Youjia</FirstName>
        <LastName>Yu</LastName>
        <affiliation locale="en_US">Department of Anesthesiology, Suzhou Xiangcheng People&#x2019;s Hospital, Suzhou, China</affiliation>
      </Author>
      <Author>
        <FirstName>Ji</FirstName>
        <LastName>Zhu</LastName>
        <affiliation locale="en_US">Department of Anesthesiology, The Second Affiliated Hospital, Wannan Medical College, Wuhu, China</affiliation>
      </Author>
      <Author>
        <FirstName>Guiru</FirstName>
        <LastName>Li</LastName>
        <affiliation locale="en_US">Department of Anesthesiology, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University,  Suzhou, China</affiliation>
      </Author>
      <Author>
        <FirstName>Xiaolin</FirstName>
        <LastName>Deng</LastName>
        <affiliation locale="en_US">Department of Anesthesiology, Suzhou Hospital, Affiliated Hospital of Medical School, Nanjing University,  Suzhou, China</affiliation>
      </Author>
      <Author>
        <FirstName>Hong</FirstName>
        <LastName>Xie</LastName>
        <affiliation locale="en_US">Department of Anesthesiology, The Second Affiliated Hospital, Soochow University, Suzhou, China</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>01</Month>
        <Day>29</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>03</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">This study aimed to explore the underlying mechanism of nebulized dexmedetomidine (DEX) in ameliorating ventilator-induced lung injury (VILI)-induced oxidative stress in rats.
Forty 7 to 8-week-old Sprague-Dawley rats at the specific pathogen-free level were randomized into the control group, model group, nebulized dexmedetomidine (WH-YM) group, and dexmedetomidine intravenous infusion (JM-YM) group, each containing 10 rats. Except for the control group, rats in the other groups underwent mechanical ventilation (tidal volume, &#xA0;40 mL/kg; respiratory rate, 70 breaths per minute; inspiratory-to-expiratory ratio, 1:2; fraction of inspired oxygen, 21%; positive end-expiratory pressure, 0 cmH2O). Nebulized DEX (6.3 &#xB5;g/kg), and isodose intravenous DEX &#xA0;were given to rats of WH-YM and JM-YM groups prior to ventilation. Post 4-hour ventilation, rats were euthanized. Lung tissue wet-to-dry weight ratio, H&amp;amp;E staining for assessing diffuse alveolar damage (DAD), and expression levels of Nrf2 and Keap1 detected by qRT-PCR and Western blot were compared. Inflammatory markers TNF-&#x3B1;, IL-2, and IL-6, and oxidative stress indices malondialdehyde (MDA) and superoxide dismutase (SOD), were quantified in lung tissues and serum samples using commercial kits.&#xA0;
Rats in the WH-YM and JM-YM groups demonstrated significant ameliorations in the wet-to-dry weight ratio and DAD score, decreased Keap1, TNF-&#x3B1;, IL-2, and IL-6 levels in lung tissues and serum samples, but increased Nrf2 and SOD level than those of controls. These changes were more pronounced in the WH-YM group than in the JM-YM group.
DEX effectively alleviates VILI-induced oxidative stress and inflammation via the Keap1-Nrf2-ARE signaling pathway., especially in the nebulized administration.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/4018</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/4018/2079</pdf_url>
  </Article>
</Articles>
